press enter »
placeholder
placeholder

UPDATE – EU regulator backs J&J shot, finds possible link to clots
UPDATE – EU regulator backs J&J shot, finds possible link to clots

UPDATE – EU regulator backs J&J shot, finds possible link to clots

Reading Time: 3 minutes April 20 (Reuters) – Europe’s drug regulator has found a possible link between Johnson & Johnson’s COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. The European Medicines Agency (EMA) said on Tuesday its safety committee had

EU regulator prepares to issue advice on use of J&J vaccine

EU regulator prepares to issue advice on use of J&J vaccine

Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected in the U.S. Last week, J&J halted its European rollout of its one-dose vaccine after the U.S. Food and Drug

J&J vaccine: EMA confirms “overall benefit-risk remains positive”

J&J vaccine: EMA confirms “overall benefit-risk remains positive”

The European Medicines Agency said on Tuesday, that with regard to the Johnson & Johnson Covid-19 Vaccine Janssen – it has found a “possible link to very rare cases of unusual blood clots with low blood platelets.” However, it also confirmed the “overall benefit-risk remains positive.” EMA’s safety committee (PRAC) concluded that a warning about unusual

EMA Gives Go-Ahead For Johnson & Johnson Jab Despite Confirmed Link To Blood Clots

EMA Gives Go-Ahead For Johnson & Johnson Jab Despite Confirmed Link To Blood Clots

Blood clots have been confirmed as a possible side effect of the Johnson & Johnson vaccine by the European Medicines Authority. This comes after EU countries suspended their rollout of the American jab following six reports of patients developing blood clots after taking the J&J jab. Over seven million US citizens have been inoculated with J&J the

Blood clots should be listed as rare Johnson & Johnson side effect - EMA

Blood clots should be listed as rare Johnson & Johnson side effect - EMA

The EU's drug regulator said Tuesday that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but that its benefits still outweighed the risks. The European Medicines Agency said in a statement it had found a "possible link" between the jab and the clot, and that its safety committee "concluded that

Possible link between Johnson & Johnson vaccine and blood clots – EMA

Possible link between Johnson & Johnson vaccine and blood clots – EMA

Photo: Macau Photo Agency on Unsplash The European Medicines Agency (EMA) found a possible link between Johnson & Johnson’s COVID-19 vaccine and cases of blood clotting disorders, reports in international media said. EMA said that a warning should be added to the vaccine’s product information, but the shot’s benefits still outweighed its risks. “Healthcare

EU regulator finds link between Johnson & Johnson vaccine and very rare blood clots

EU regulator finds link between Johnson & Johnson vaccine and very rare blood clots

Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine's benefits still outweighed the very small risks of recipients developing

Researchers Are Looking Into Whether COVID-19 Vaccines Affect Women Differently

Researchers Are Looking Into Whether COVID-19 Vaccines Affect Women Differently

Researchers are looking into whether certain vaccines against COVID-19 affect women differently than men, after the majority of patients who reported developing blood clots after taking an AstraZeneca and Johnson & Johnson jab were female. As of 4th April, the European Medicines Agency received 169 reports of a particular kind of blood clot, called

COVID-19 vaccine-makers largely protected on side effects

COVID-19 vaccine-makers largely protected on side effects

Pharmaceuticals making COVID vaccines are largely protected legally in the event of harmful side effects, like blood clots that have been linked to jabs from AstraZeneca and Johnson & Johnson. However while some governments will pay compensation due to sufferers, others assume it is the responsibility of the companies even after drugs agencies back

Philippines lifts suspension on AstraZeneca vaccine for under 60s

Philippines lifts suspension on AstraZeneca vaccine for under 60s

Reading Time: 2 minutes The Philippines will resume administering AstraZeneca’s COVID-19 vaccine to people below 60 years of age, health officials said on Monday, ending a temporary suspension over reports of rare blood clots in younger recipients overseas. “The benefit outweighs the risk. Only a small percentage of the population had these adverse